Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1990 1
1994 1
1995 1
1996 1
1998 3
1999 4
2000 1
2002 2
2003 1
2004 4
2005 3
2006 2
2008 2
2011 1
2016 1
2017 1
2018 4
2019 3
2020 1
2021 1
2022 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles.
Eekhoff EMW, de Ruiter RD, Smilde BJ, Schoenmaker T, de Vries TJ, Netelenbos C, Hsiao EC, Scott C, Haga N, Grunwald Z, De Cunto CL, di Rocco M, Delai PLR, Diecidue RJ, Madhuri V, Cho TJ, Morhart R, Friedman CS, Zasloff M, Pals G, Shim JH, Gao G, Kaplan F, Pignolo RJ, Micha D. Eekhoff EMW, et al. Among authors: netelenbos c. Hum Gene Ther. 2022 Aug;33(15-16):782-788. doi: 10.1089/hum.2022.023. Hum Gene Ther. 2022. PMID: 35502479 Free PMC article. Review.
Osteoporosis: intervention options.
Netelenbos C. Netelenbos C. Maturitas. 1998 Nov 16;30(3):235-9. doi: 10.1016/s0378-5122(98)00091-7. Maturitas. 1998. PMID: 9881322 Review.
Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP).
Hsiao EC, Di Rocco M, Cali A, Zasloff M, Al Mukaddam M, Pignolo RJ, Grunwald Z, Netelenbos C, Keen R, Baujat G, Brown MA, Cho TJ, De Cunto C, Delai P, Haga N, Morhart R, Scott C, Zhang K, Diecidue RJ, Friedman CS, Kaplan FS, Eekhoff EMW. Hsiao EC, et al. Among authors: netelenbos c. Br J Clin Pharmacol. 2019 Jun;85(6):1199-1207. doi: 10.1111/bcp.13777. Epub 2018 Nov 6. Br J Clin Pharmacol. 2019. PMID: 30281842 Free PMC article. Review.
[Bisphosphonate-related osteonecrosis of the jaw].
Franken AA, van Blijderveen NJ, Witjes MJ, Netelenbos CJ. Franken AA, et al. Among authors: netelenbos cj. Ned Tijdschr Geneeskd. 2011;155:A3077. Ned Tijdschr Geneeskd. 2011. PMID: 21486510 Review. Dutch.
Limitations of Jaw Movement in Fibrodysplasia Ossificans Progressiva: A Review.
Schoenmaker T, Dahou Bouchankouk A, Özkan S, Gilijamse M, Bouvy-Berends E, Netelenbos C, Lobbezoo F, Eekhoff EMW, de Vries TJ. Schoenmaker T, et al. Among authors: netelenbos c. Front Med (Lausanne). 2022 Mar 22;9:852678. doi: 10.3389/fmed.2022.852678. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35391888 Free PMC article. Review.
Activin-A Induces Fewer, but Larger Osteoclasts From Monocytes in Both Healthy Controls and Fibrodysplasia Ossificans Progressiva Patients.
Schoenmaker T, Botman E, Sariyildiz M, Micha D, Netelenbos C, Bravenboer N, Kelder A, Eekhoff EMW, De Vries TJ. Schoenmaker T, et al. Among authors: netelenbos c. Front Endocrinol (Lausanne). 2020 Jul 14;11:501. doi: 10.3389/fendo.2020.00501. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32760351 Free PMC article.
38 results